NOT:ETR
Novartis AG
€137.04
arrow_upward
+0.41%(+0.56) 1D
Oct 21, 5:35:53 PM GMT+2 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for NOT...
Open
€136.56
High
€137.28
Low
€136.02
Mkt. cap
312.75B
Avg. vol.
7.35K
Volume
2.79K
52-wk high
€144.12
52-wk low
€104.52
No. of employees
75K
Open
€136.56
High
€137.28
Low
€136.02
Mkt. cap
312.75B
Avg. vol.
7.35K
Volume
2.79K
52-wk high
€144.12
52-wk low
€104.52
No. of employees
75K
News stories
From web sources and news partners
Yahoo Finance
·
2 hours ago
Novartis (NVS) Grew Sales Again as Entresto Fell 50%, Can Remibrutinib Carry It?
Yahoo Finance
·
5 hours ago
Novartis receives European Commission approval for Cosentyx® in polymyalgia rheumatica (PMR)
AD HOC NEWS
·
5 hours ago
Novartis stock: UBS keeps Hold rating and CHF 116.00 target for Novartis stock
AD HOC NEWS
·
13 hours ago
Novartis stock has investor call on October 23 ahead of Xetra open
Profile
Novartis AG is a Swiss multinational pharmaceutical corporation based in Basel, Switzerland. Novartis is one of the largest pharmaceutical companies in the world and was the eighth largest by revenue in 2024.
Novartis manufactures the drugs clozapine, diclofenac, carbamazepine, valsartan, imatinib mesylate, cyclosporine, letrozole, methylphenidate, terbinafine, deferasirox, and others.
Novartis was formed in 1996 by the merger of Ciba-Geigy and Sandoz. It was considered the largest corporate merger in history during that time. The pharmaceutical and agrochemical divisions of both companies formed Novartis as an independent entity. The name Novartis was based on the Latin terms, novae artes.
After the merger, other Ciba-Geigy and Sandoz businesses were sold, or, like Ciba Specialty Chemicals, spun off as independent companies. The Sandoz brand disappeared for three years, but was revived in 2003 when Novartis consolidated its generic drugs businesses into a single subsidiary and named it Sandoz. Wikipedia
About Novartis AG
CEOVasant Narasimhan
Employees75.3K
FoundedMar 7, 1996
HeadquartersBasel, Basel City, Switzerland
SectorPharmaceutical industry
Websitenovartis.com